Biomea Fusion BMEA
NASDAQ BMEA
$1.77 +0.06 (+3.51%)
As of: Sep 22, 2026 · 10:24 AM EDT

Biomea Fusion (BMEA) Shares Outstanding (2020 - 2026)

Biomea Fusion's (BMEA) quarterly Shares Outstanding (Entity) came in at $72.5 million in Q2 2026, up 78.4% year-over-year from $40.6 million in Q2 2025, and little changed quarter-over-quarter from $72.3 million in Q1 2026.

Analysis

Biomea Fusion (BMEA) Shares Outstanding (2020 - 2026) Analysis & Trends

Biomea Fusion has disclosed Shares Outstanding (Entity) across 7 years of filings, most recently posting $72.5 million for Q2 2026.

  • In Q2 2026, Shares Outstanding (Entity) rose 78.4% year-over-year to $72.5 million; the TTM figure through Jun 2026 stood at $72.5 million (up 78.4% YoY), while the FY2025 annual figure was $52.2 million, up 43.84% from the prior year.
  • Shares Outstanding (Entity) came in at $72.5 million for Q2 2026 at Biomea Fusion, roughly flat from $72.3 million in the prior quarter.
  • In the past five years, Shares Outstanding (Entity) ranged from a high of $72.5 million in Q2 2026 to a low of $29.2 million in Q1 2022.
  • Average Shares Outstanding (Entity) over 5 years is $40.8 million, with a median of $36.1 million recorded in 2024.
  • The largest YoY upside for Shares Outstanding (Entity) was 142.98% in 2022 against a maximum downside of 1.0% in 2022.
  • Over 5 years, Shares Outstanding (Entity) stood at $29.6 million in 2022, then grew by 21.33% to $35.9 million in 2023, then gained by 1.24% to $36.3 million in 2024, then soared by 43.84% to $52.2 million in 2025, then jumped by 38.78% to $72.5 million in 2026.
  • Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $72.5 million in Q2 2026, $72.3 million in Q1 2026, and $52.2 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn 2.41 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn 1.77 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn 1.94 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn 5.70 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn 2.04 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn 1.22 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn - 210.89 Mn
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn 111.58 Mn
10 Biomea Fusion 132.65 Mn 132.65 Mn - 72.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 72.36 Mn
Mar 31, 2026 72.30 Mn
Dec 31, 2025 52.23 Mn
Sep 30, 2025 59.85 Mn
Jun 30, 2025 40.63 Mn
Mar 31, 2025 36.63 Mn
Dec 31, 2024 36.11 Mn
Sep 30, 2024 36.22 Mn
Jun 30, 2024 36.04 Mn
Mar 31, 2024 35.89 Mn
Dec 31, 2023 34.11 Mn
Sep 30, 2023 35.65 Mn
Jun 30, 2023 35.35 Mn
Mar 31, 2023 29.59 Mn
Dec 31, 2022 29.27 Mn
Sep 30, 2022 29.32 Mn
Jun 30, 2022 29.20 Mn
Mar 31, 2022 29.13 Mn
Dec 31, 2021 23.86 Mn
Sep 30, 2021 29.00 Mn
API Access

Biomea Fusion Shares Outstanding API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding&ticker=BMEA&period=max&api_key=YOUR_API_KEY